FORM SC 13D

Company

Protalix BioTherapeutics, Inc.

Filed

July 29, 2008

Accession Number

0000950123-08-008431

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →